AF
BLUE

Amalgamated Financial’s bluebird bio BLUE Stock Holding History

Amalgamated Financial’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$39K Buy
+407
New +$53.7K ﹤0.01% 2530

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Amalgamated Financial's BLUE Position: Q1 2022 in Review

Amalgamated Financial opened a new position in bluebird bio (BLUE) in Q1 2022: 407 shares worth $39K. The stake represents ﹤0.01% of the portfolio and ranks #2530 among its holdings.

174 funds tracked by Wall St. Rank hold BLUE as of Q1 2022.

  • Amalgamated Financial held 407 shares of bluebird bio worth $39K as of Q1 2022.
  • bluebird bio was a new Amalgamated Financial position in Q1 2022.
  • bluebird bio made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2530 holding.
  • 174 funds tracked by Wall St. Rank held bluebird bio as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.